Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Phase II Exploratory Clinical Study Investigating the Geroprotective Effect of Metformin in Middle-aged and Elderly People

Authors not listed

Xuanwu Hospital, Beijing · 2024

Cellular senescence Metformin Human Randomized controlled trial

Abstract

The objective of this research is to assess the efficacy of oral metformin in mitigating the aging process in middle-aged and elderly males, to pinpoint sensitive indicators of human senescence, and to offer innovative frameworks and scientific insights for pharmaceutical interventions in aging.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-16 MST

Cite this

APA

Anonymous. (2024). A Phase II Exploratory Clinical Study Investigating the Geroprotective Effect of Metformin in Middle-aged and Elderly People. <em>Xuanwu Hospital, Beijing</em>. https://clinicaltrials.gov/study/NCT06459310

Vancouver

Anonymous. A Phase II Exploratory Clinical Study Investigating the Geroprotective Effect of Metformin in Middle-aged and Elderly People. Xuanwu Hospital, Beijing. 2024.

BibTeX

@misc{anon2024APhase, title = {A Phase II Exploratory Clinical Study Investigating the Geroprotective Effect of Metformin in Middle-aged and Elderly People}, author = {Anonymous}, journal = {Xuanwu Hospital, Beijing}, year = {2024}, }